Global market trends

The Nasdaq Composite gained 2% and the Nikkei added 1%, while the Korean Composite remained...

Premium Content
Monthly Digital Access

Subscribe

Already A Subscriber?
Login
Yearly Digital+Print Access

Subscribe

Moneylife Magazine Subscriber or MSSN member?
Login

Yearly Subscriber Login

Enter the mail id that you want to use & click on Go. We will send you a link to your email for verficiation
Orchid Chemicals gets USFDA approval for anti-depression capsule

Orchid Chemicals has received final approval from the US health regulator for its generic Venlafaxine capsules, used in the treatment of depression

Drug firm Orchid Chemicals & Pharmaceuticals today said it has received final approval from the US health regulator for its generic Venlafaxine capsules, used in the treatment of depression.

The final approval from the United States Food and Drug Administration (USFDA) is forits abbreviated new drug application (ANDA) for Venlafaxine extended release capsules in strengths of 37.5mg, 75mg and 150mg, Orchid Chemicals & Pharmaceuticals said in a filing tothe Bombay Stock Exchange (BSE).

Venlafaxine extended release capsules are used for treating major depressive disorders (MDD)and falls under the central nervous system (CNS) category. Venlafaxine was introduced by drug-maker Wyeth in 1993 under the brand name Effexor.On Thursday, Orchid Chemicals ended 0.14% up at Rs252.10 on the Bombay Stock Exchange,while the benchmark Sensex gained 0.12% to 18,618.20.

User

What’s hot

Stocks of telecom companies were on the buyers’ radar—Idea Cellular climbed 4% and Bharti Airtel...

Premium Content
Monthly Digital Access

Subscribe

Already A Subscriber?
Login
Yearly Digital+Print Access

Subscribe

Moneylife Magazine Subscriber or MSSN member?
Login

Yearly Subscriber Login

Enter the mail id that you want to use & click on Go. We will send you a link to your email for verficiation

We are listening!

Solve the equation and enter in the Captcha field.
  Loading...
Close

To continue


Please
Sign Up or Sign In
with

Email
Close

To continue


Please
Sign Up or Sign In
with

Email

BUY NOW

The Scam
24 Year Of The Scam: The Perennial Bestseller, reads like a Thriller!
Moneylife Magazine
Fiercely independent and pro-consumer information on personal finance
Stockletters in 3 Flavours
Outstanding research that beats mutual funds year after year
MAS: Complete Online Financial Advisory
(Includes Moneylife Magazine and Lion Stockletter)